Paeds Vivas · clinical-pharmacology-and-therapeutics
Opioids and acute pain medicines — branching viva
A branching viva following one child from post-tonsillectomy analgesia through the codeine contraindication and the CYP2D6 prodrug mechanism, on to building a safe weight-based morphine regimen, detecting opioid-induced respiratory depression early, and reversing it with naloxone.
On this page & tools
Target exams
Opening — choosing the regimen
Examiner: A four-year-old, 16-kilogram boy is admitted overnight after adenotonsillectomy for obstructive sleep apnoea. The on-call team has written for paracetamol, ibuprofen, and codeine. Talk me through that prescription. [1]
Model answer — opening
I would stop the codeine immediately. Codeine is contraindicated in children under 12 years and for postoperative pain after tonsillectomy or adenoidectomy in children under 18 years. [1] [2] This child sits squarely in both contraindicated groups: he is four years old and he has just had a tonsillectomy. I would replace it with a safe modern regimen — scheduled paracetamol and ibuprofen, with oral morphine or oxycodone as rescue — and because he has obstructive sleep apnoea I would monitor him overnight with continuous oximetry, use the smallest effective opioid dose, and avoid any background infusion. [6] [9]
Branch 1 — defending the contraindication
Examiner: Why is codeine contraindicated? Explain the pharmacology. [2]
Model answer — the mechanism
Codeine is a prodrug with little analgesic activity of its own. About 5 to 10 per cent of a dose is converted by the cytochrome P450 2D6 enzyme — CYP2D6 — into morphine, and it is the morphine that produces the analgesia. CYP2D6 activity is genetically determined, so the conversion is unpredictable: an ultrarapid metaboliser generates a dangerous excess of morphine from a normal codeine dose, and a poor metaboliser generates almost none. Because you cannot tell an ultrarapid metaboliser at the bedside, every child carries the risk. Tramadol is contraindicated for the same reason — CYP2D6 converts it to the active O-desmethyltramadol. [2] [3]
Examiner: What event drove the contraindication? [1]
Model answer — the driving event
A series of deaths from respiratory depression in young children, many of them CYP2D6 ultrarapid metabolisers, following tonsillectomy or adenoidectomy for obstructive sleep apnoea. These children were exactly this child — young, airway-sensitive, and given codeine after their airway surgery. The United States Food and Drug Administration issued a boxed warning, and the United Kingdom and European regulators issued contraindications. The risk was judged unacceptable because safer alternatives exist. [1] [2]
Branch 2 — building the morphine plan
Examiner: He is still in severe pain at 22:00 despite paracetamol and ibuprofen. What opioid will you give and how much? [6]
Model answer — weight-based morphine
For severe acute pain I would give intravenous morphine 0.1 to 0.2 milligram per kilogram titrated slowly in increments — for a 16-kilogram child that is 1.6 to 3.2 milligrams — reassessing after each increment until the pain is controlled. For ongoing pain I would use either oral morphine 0.2 to 0.5 milligram per kilogram every four hours or, if intravenous analgesia is needed, a morphine infusion at 10 to 40 microgram per kilogram per hour. Given his age and the obstructive sleep apnoea, I would start at the lower end, monitor continuously, and avoid a background infusion in this opioid-naive child. I would also prescribe a prophylactic stimulant laxative from the first dose, because opioid constipation is near-universal. [6] [9]
Branch 3 — recognising the deterioration
Examiner: At 02:00 the nurse calls. He is hard to rouse and his respiratory rate has dropped to 8. What is happening and what is your first move? [9]
Model answer — respiratory depression
He has opioid-induced respiratory depression. The earliest sign is a reduction in the depth and then the rate of breathing with rising sedation — which is exactly what the nurse is describing — and oxygen saturation falls late. My first moves are to stimulate him, open and support his airway, and provide bag-valve-mask ventilation if his breathing is inadequate, then give naloxone titrated to his respiratory rate rather than to full consciousness. [9]
Branch 4 — naloxone
Examiner: Give me the naloxone dose, route, and the principle of titration. [11]
Model answer — naloxone
I would give naloxone 10 microgram per kilogram intravenously — about 160 microgram for a 16-kilogram child — repeated every two to three minutes until his respiratory effort is restored. If I cannot get intravenous access quickly, intramuscular or intranasal naloxone is an option and is rapidly absorbed. The principle of titration is essential: the goal is to restore adequate breathing, not to render him fully awake, because a large naloxone dose precipitates acute opioid withdrawal, uncontrolled pain, and agitation. Because naloxone has a short half-life — about 30 to 80 minutes — and is shorter than morphine, I would observe him for renarcotisation and consider a naloxone infusion if he re-sedates. [11]
Closing — the system lesson
Examiner: What does this case teach you about prescribing opioids to children? [10]
Model answer — the system lesson
Three things. First, codeine and tramadol have no place in paediatric analgesia — the contraindication must live in the prescriber's head, not only in the decision-support software. Second, every opioid regimen needs paired pain and sedation scoring — a rising sedation score is the warning before apnoea, and recording it together is the cheapest, most reliable monitor. Third, the opioid-naive child should never receive a background infusion — bolus with lockout lets the child protect themselves, and naloxone must always be at the bedside. With these habits — the right drug, the right monitoring, no background infusion, and naloxone available — opioids remain effective and necessary for the child in real pain. [9] [10]
References
- [1]Racoosin, Judith A; Roberson, David W; Pacanowski, Mark A; et al New evidence about an old drug — risk with codeine after adenotonsillectomy New England Journal of Medicine, 2013.PMID 23614474
- [2]Tobias, Joseph D; Green, Thomas P; Coté, Charles J; et al Codeine: Time to Say No Pediatrics, 2016.PMID 27647717
- [3]Pratt, Victoria M; Scott, Stuart A; Pirmohamed, Munir; et al Tramadol Therapy and CYP2D6 Genotype Clinical Pharmacology and Therapeutics, 2012.PMID 28520365
- [6]Lynn, Anne; Nespeca, Mary K; Bratton, Sunkyung L; et al Clearance of morphine in postoperative infants during intravenous infusion: the influence of age and surgery Anesthesia and Analgesia, 1998.PMID 9585276
- [9]Niesters, Monique; Overdyk, Frank; Smith, Thornton; et al Opioid-induced respiratory depression in paediatrics: a review of case reports British Journal of Anaesthesia, 2013.PMID 23248093
- [10]Sharp, Debra; Jaffrani, Aliasgar A PRISMA Systematic Review on the Safety and Efficacy of Patient-Controlled Analgesia (PCA) in Pediatrics Journal of Pediatric Nursing, 2021.PMID 34139608
- [11]Malmros Olsson, Elisabet; Lonnqvist, Per-Arne; Stiller, Cari O; et al Rapid systemic uptake of naloxone after intranasal administration in children Paediatric Anaesthesia, 2021.PMID 33687794